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Department. Thus, the patient becomes a key actor in the 
quality and safety of its own treatment. 
In conclusions: empowerment of the patient is essential for 
two reasons, on one hand at the individual level by 
strengthening its capacity to act on health determinants and 
on the other hand at the organizational level with continuous 
improvement of the Radiotherapy Department. Our goal is to 
strengthen the quality and safety of treatments, adjust them 
to the life project of the patient and promote a participative 
approach focused on the patient’s needs and expectations.  
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It has often been claimed and acknowledged that 
Radiotherapy (RT) as a modality to combat cancer has been 
technology driven, or even physicist driven. Higher energies, 
better accuracy, computerised delivery systems, 
improvements in imaging are all examples of this. Together 
with increased knowledge of how to combine RT with e.g. 
systemic treatments, RT has remained one of the most 
important tools in cancer therapy. The continuous 
improvements of RT has often involved complex technology, 
less intuitive to its nature than earlier technologies. It has 
been one of the most pronounced duties of the medical 
physicist to ensure that the clinical introduction of such new 
technologies has been done with the highest possible safety 
standards and that any risk associated with the new 
technology could be brought to an absolute minimum. As a 
result RT, in particular advanced RT, is a very safe modality 
compared to almost any other hospital activities. In their 
quest for the highest possible level of safety, the medical 
physicist is often left alone with high demands, ambitions but 
with limited means and lack of understanding from the 
hospital management of the recourses needed. As a 
consequence the clinical introduction of new, superior 
treatment options are delayed, months, years and sometimes 
even decades, and the patients have to be content with older 
methods, e.g. less conformal RT. This dilemma can be boiled 
down to the search for the optimal balance between quality 
(e.g. modern high precision treatments) and safety (reliable, 
well proven and understood methods). The priority often 
tends to go towards safety rather than quality since the focus 
from the general public as well as regulatory authorities 
always favours the latter at the expense of the former. As 
medical physicists, however tempting it might be to focus on 
safety only, must take a patient oriented approach and in all 
considerations include the aspect of what will be the most 
beneficial way from a patient’s perspective. Just as a high 
quality cannot be justified to apply is the safety issues are 
not properly handled, safety without quality is of limited 
value. In the search for the ultimate balance between quality 
and safety, the medical physicist is in a key position since no 
other profession has a better understanding of the 
technology, the physics and the interactions between 
different complex systems. A more patient-centred approach 
to accuracy, safety and quality can, however only result from 
a multidisciplinary strategy where different profession work 
together towards the common goal to offer the best possible 
treatment to all patients in need thereof. 
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Purpose or Objective: Current IMRT treatment planning with 
commercial treatment planning systems is a trial-and-error 
process, based on a series of subjective human decisions. So 
the quality of the IMRT treatment plans may not be 
consistent among patients, planners or institutions with 
different experience. Different plan quality assurance (QA) 
tools have been proposed recently, that could flag 
suboptimal plans that may benefit from an additional 
treatment planning effort. However, since conventional 
treatment planning was used to validate these models, the 
inherent accuracy of the existing treatment planning QA 
models is unknown. Therefore we fully automatically 
generated a dataset of Pareto-optimal prostate IMRT plans 
using Erasmus – iCycle, an in-house TPS for fully automated, 
multi-criterial plan generation. This dataset was used to 
assess the prediction accuracy of an overlap volume 
histogram (OVH) based plan QA tool. 
 
Material and Methods: 115 prostate plans were fully 
automatically generated using Erasmus-iCycle. These plans 
were based on a fixed ‘wish-list’ which contains hard 
constraints and objectives in a predefined order of priority. 
An existing OVH model was modified and used to predict 
DVHs for these patients. First, the entire DVH of the rectum, 
bladder and anus of a validation cohort (N=57) were 
predicted, using the plans of an independent training cohort 
(N=58). To investigate the impact on prediction accuracy of 
an enlarged training cohort, the DVHs were also predicted by 
a leave-one-out method. The predicted rectum Dmean, V65, 
and V75, and Dmean of the anus and bladder were compared 
with the achieved values to validate the OVH QA tool. 
 
Results: For rectum, the prediction errors (predicted-
achieved) were small: -0.2±0.9 Gy (mean±1 SD) for Dmean, -
1.0±1.6% for V65, and -0.4±1.1% for V75. 72% and 96% of the 
predicted rectum Dmean had prediction errors within 1 Gy 
and 2 Gy, respectively. For Dmean of anus the prediction 
error was only 0.1±1.6 Gy, whereas for the bladder it was 
much larger: and 4.8±4.1 Gy (see also Fig 1). Increasing the 
training cohort to 114 patients (using leave-one-out) led to 
minor improvement. 
 
Conclusion: A dataset of consistently prioritized Pareto-
optimal prostate IMRT plans was generated. This dataset can 
be used to validate any planning QA model and will be made 
publicly available at the Treatment Planning QA Section of 
http://www.erasmusmc.nl/radiotherapie/research/radiation
oncologymedicalphysicsandimaging/research_projects. It was 
applied here to assess the accuracy of the OVH model. The 
OVH model was highly accurate in predicting rectum and anus 
DVHs. For the bladder large prediction errors were observed, 
which indicates that the OVH has difficulty in capturing the 
interdependence of sparing different OARs. We are currently 
